• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于数据库和信息学分析的miR-501-3p在卵巢癌中的表达、临床意义及潜在信号通路

Expression, Clinical Significance, and Prospective Pathway Signaling of miR-501-3p in Ovarian Cancer Based on Database and Informatics Analysis.

作者信息

Chen Buze, Jin Xin, Wang Haihong, Zhou Qingmei, Li Guilin, Lu Xiaoyuan

机构信息

Department of Gynecology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, People's Republic of China.

Xuzhou Medical University, Xuzhou, Jiangsu, 221000, People's Republic of China.

出版信息

Int J Gen Med. 2021 Sep 3;14:5193-5201. doi: 10.2147/IJGM.S327673. eCollection 2021.

DOI:10.2147/IJGM.S327673
PMID:34512002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8423717/
Abstract

BACKGROUND

The present study aims to explore the expression, clinical significance, and prospective pathway signaling of miR-501-3p in ovarian cancer (OC) based on database and informatics analysis.

METHODS

Kruskal-Wallis test, Wilcoxon sign-rank test, and logistic regression were used to evaluate the relationship between clinical features and miR-501-3p expression. Kaplan-Meier survival curve analysis was used to explore the relationship between miR-501-3p expression and the prognosis of OC patients. The miRNA targets were obtained from databases TargetScan, miRanda, TarBase, miRTarBase, miR2Disease, miRecords, and miRWalk. GO and KEGG analyses were used to analyze the significant involvement of miR-501-3p target genes in function.

RESULTS

The low miR-501-3p expression in OC was significantly associated with histologic grade (P=0.015). Low miR-501-3p expression predicted a poorer overall survival (HR: 0.77; 95% CI: 0.61-0.96; P=0.02) and disease-specific survival (HR: 0.77; 95% CI: 0.61-0.99; P=0.038). GO and KEGG analyses demonstrated that miR-501-3p might participate in the development of OC by pathways including one carbon pool by folate, protein digestion and absorption, cell cycle, kaposi sarcoma-associated herpesvirus infection, and viral carcinogenesis.

CONCLUSIONS

Low miR-501-3p expression is significantly associated with poor survival in OC patients. It may be a promising prognostic biomarker for OC patients.

摘要

背景

本研究旨在基于数据库和信息学分析,探讨miR-501-3p在卵巢癌(OC)中的表达、临床意义及潜在的信号通路。

方法

采用Kruskal-Wallis检验、Wilcoxon符号秩检验和逻辑回归评估临床特征与miR-501-3p表达之间的关系。使用Kaplan-Meier生存曲线分析探讨miR-501-3p表达与OC患者预后的关系。从TargetScan、miRanda、TarBase、miRTarBase、miR2Disease、miRecords和miRWalk数据库中获取miRNA靶点。使用GO和KEGG分析来分析miR-501-3p靶基因在功能上的显著参与情况。

结果

OC中miR-501-3p低表达与组织学分级显著相关(P=0.015)。miR-501-3p低表达预示着较差的总生存期(HR:0.77;95%CI:0.61-0.96;P=0.02)和疾病特异性生存期(HR:0.77;95%CI:0.61-0.99;P=0.038)。GO和KEGG分析表明,miR-501-3p可能通过包括叶酸一碳池、蛋白质消化与吸收、细胞周期、卡波西肉瘤相关疱疹病毒感染和病毒致癌作用等途径参与OC的发生发展。

结论

miR-5

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd5/8423717/ed0728f281d8/IJGM-14-5193-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd5/8423717/ae5338b0450f/IJGM-14-5193-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd5/8423717/b4e99be15a6e/IJGM-14-5193-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd5/8423717/1430f71038d7/IJGM-14-5193-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd5/8423717/232c9debf9b9/IJGM-14-5193-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd5/8423717/5c4d6225fcf8/IJGM-14-5193-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd5/8423717/ed0728f281d8/IJGM-14-5193-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd5/8423717/ae5338b0450f/IJGM-14-5193-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd5/8423717/b4e99be15a6e/IJGM-14-5193-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd5/8423717/1430f71038d7/IJGM-14-5193-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd5/8423717/232c9debf9b9/IJGM-14-5193-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd5/8423717/5c4d6225fcf8/IJGM-14-5193-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd5/8423717/ed0728f281d8/IJGM-14-5193-g0006.jpg

相似文献

1
Expression, Clinical Significance, and Prospective Pathway Signaling of miR-501-3p in Ovarian Cancer Based on Database and Informatics Analysis.基于数据库和信息学分析的miR-501-3p在卵巢癌中的表达、临床意义及潜在信号通路
Int J Gen Med. 2021 Sep 3;14:5193-5201. doi: 10.2147/IJGM.S327673. eCollection 2021.
2
miR-149-3p Is a Potential Prognosis Biomarker and Correlated with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma.miR-149-3p是子宫体子宫内膜癌潜在的预后生物标志物,且与免疫浸润相关。
Int J Endocrinol. 2022 Jun 8;2022:5006123. doi: 10.1155/2022/5006123. eCollection 2022.
3
MiR-195-3p is a Novel Prognostic Biomarker Associated with Immune Infiltrates of Lung Adenocarcinoma.MiR-195-3p是一种与肺腺癌免疫浸润相关的新型预后生物标志物。
Int J Gen Med. 2022 Jan 6;15:191-203. doi: 10.2147/IJGM.S350340. eCollection 2022.
4
Prospective pathway signaling and prognostic values of MicroRNA-9 in ovarian cancer based on gene expression omnibus (GEO): a bioinformatics analysis.基于基因表达综合数据库(GEO)的卵巢癌中 MicroRNA-9 的前瞻性通路信号和预后价值:一项生物信息学分析。
J Ovarian Res. 2021 Feb 9;14(1):29. doi: 10.1186/s13048-021-00779-z.
5
Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.miR-182 在卵巢癌中的预后价值及潜在通路信号分析:基于基因表达综合数据库(GEO)和生物信息学分析的研究。
J Ovarian Res. 2019 Nov 8;12(1):106. doi: 10.1186/s13048-019-0580-7.
6
Clinical significance of miR-1180-3p in hepatocellular carcinoma: a study based on bioinformatics analysis and RT-qPCR validation.miR-1180-3p 在肝细胞癌中的临床意义:基于生物信息学分析和 RT-qPCR 验证的研究。
Sci Rep. 2020 Jul 14;10(1):11573. doi: 10.1038/s41598-020-68450-z.
7
The miRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling lncRNA TUG1.miR-582-3p 通过靶向 AKT/MTOR 信号 lncRNA TUG1 抑制卵巢癌细胞进展。
Bioengineered. 2021 Dec;12(2):10771-10781. doi: 10.1080/21655979.2021.2003662.
8
The Immune-Related Gene ELF3 is a Novel Biomarker for the Prognosis of Ovarian Cancer.免疫相关基因ELF3是卵巢癌预后的新型生物标志物。
Int J Gen Med. 2021 Sep 10;14:5537-5548. doi: 10.2147/IJGM.S332320. eCollection 2021.
9
Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicity.乳腺癌患者外周血 miRNA 与蒽环类药物心脏毒性关系的生物信息学分析。
BMC Cardiovasc Disord. 2020 Feb 3;20(1):43. doi: 10.1186/s12872-020-01346-y.
10
MiR-149-3p promotes the cisplatin resistance and EMT in ovarian cancer through downregulating TIMP2 and CDKN1A.miR-149-3p 通过下调 TIMP2 和 CDKN1A 促进卵巢癌细胞顺铂耐药和 EMT。
J Ovarian Res. 2021 Nov 19;14(1):165. doi: 10.1186/s13048-021-00919-5.

引用本文的文献

1
The Role of microRNA in the Prognosis and Diagnosis of Ovarian Cancer.微小RNA在卵巢癌预后和诊断中的作用
Int J Mol Sci. 2025 Apr 5;26(7):3413. doi: 10.3390/ijms26073413.
2
Identification of target hub genes and construction of a novel miRNA regulatory network in autism spectrum disorder by integrated analysis.综合分析鉴定自闭症谱系障碍的靶标枢纽基因并构建新的 miRNA 调控网络。
Medicine (Baltimore). 2023 Jul 21;102(29):e34420. doi: 10.1097/MD.0000000000034420.
3
Identification of Driver Genes and miRNAs in Ovarian Cancer through an Integrated In-Silico Approach.

本文引用的文献

1
Bioinformatics Analysis of KIF1A Expression and Gene Regulation Network in Ovarian Carcinoma.卵巢癌中KIF1A表达及基因调控网络的生物信息学分析
Int J Gen Med. 2021 Jul 21;14:3707-3717. doi: 10.2147/IJGM.S323591. eCollection 2021.
2
MiR-585-3p suppresses tumor proliferation and migration by directly targeting CAPN9 in high grade serous ovarian cancer.miR-585-3p 通过直接靶向 CAPN9 抑制高级别浆液性卵巢癌中的肿瘤增殖和迁移。
J Ovarian Res. 2021 Jul 8;14(1):90. doi: 10.1186/s13048-021-00841-w.
3
MiR-501-3p promotes osteosarcoma cell proliferation, migration and invasion by targeting BCL7A.
通过综合计算机模拟方法鉴定卵巢癌中的驱动基因和微小RNA
Biology (Basel). 2023 Jan 26;12(2):192. doi: 10.3390/biology12020192.
4
Expression, Clinical Significance, Immune Infiltration, and Regulation Network of miR-3940-5p in Lung Adenocarcinoma Based on Bioinformatic Analysis and Experimental Validation.基于生物信息学分析和实验验证的miR-3940-5p在肺腺癌中的表达、临床意义、免疫浸润及调控网络
Int J Gen Med. 2022 Aug 6;15:6451-6464. doi: 10.2147/IJGM.S375761. eCollection 2022.
5
miR-149-3p Is a Potential Prognosis Biomarker and Correlated with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma.miR-149-3p是子宫体子宫内膜癌潜在的预后生物标志物,且与免疫浸润相关。
Int J Endocrinol. 2022 Jun 8;2022:5006123. doi: 10.1155/2022/5006123. eCollection 2022.
6
MiR-195-3p is a Novel Prognostic Biomarker Associated with Immune Infiltrates of Lung Adenocarcinoma.MiR-195-3p是一种与肺腺癌免疫浸润相关的新型预后生物标志物。
Int J Gen Med. 2022 Jan 6;15:191-203. doi: 10.2147/IJGM.S350340. eCollection 2022.
miR-501-3p 通过靶向 BCL7A 促进骨肉瘤细胞的增殖、迁移和侵袭。
Hum Cell. 2021 Mar;34(2):624-633. doi: 10.1007/s13577-020-00468-x. Epub 2021 Jan 7.
4
Tumor suppressor miR-424-5p abrogates ferroptosis in ovarian cancer through targeting ACSL4.肿瘤抑制因子 miR-424-5p 通过靶向 ACSL4 来消除卵巢癌细胞中的铁死亡。
Neoplasma. 2021 Jan;68(1):165-173. doi: 10.4149/neo_2020_200707N705. Epub 2020 Oct 7.
5
Circ-ZNF609 Accelerates the Radioresistance of Prostate Cancer Cells by Promoting the Glycolytic Metabolism Through miR-501-3p/HK2 Axis.环状锌指蛋白609通过miR-501-3p/己糖激酶2轴促进糖酵解代谢,从而加速前列腺癌细胞的放射抗性。
Cancer Manag Res. 2020 Aug 20;12:7487-7499. doi: 10.2147/CMAR.S257441. eCollection 2020.
6
The suppressive role of miR-362-3p in epithelial ovarian cancer.miR-362-3p在上皮性卵巢癌中的抑制作用。
Heliyon. 2020 Jul 7;6(7):e04258. doi: 10.1016/j.heliyon.2020.e04258. eCollection 2020 Jul.
7
Diagnostic significance of serum miR-26b and miR-21 expressions in ovarian cancer and their associations with clinicopathological characteristics and prognosis of patients.血清 miR-26b 和 miR-21 表达在卵巢癌中的诊断意义及其与患者临床病理特征和预后的关系。
Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):1697-1703. doi: 10.26355/eurrev_202002_20344.
8
MiR-501-3p functions as a tumor suppressor in non-small cell lung cancer by downregulating RAP1A.miR-501-3p 通过下调 RAP1A 发挥非小细胞肺癌肿瘤抑制因子的作用。
Exp Cell Res. 2020 Feb 1;387(1):111752. doi: 10.1016/j.yexcr.2019.111752. Epub 2019 Dec 2.
9
Dysregulation of pseudogene/lncRNA-hsa-miR-363-3p-SPOCK2 pathway fuels stage progression of ovarian cancer.假基因/长链非编码RNA-hsa-miR-363-3p-SPOCK2通路失调促进卵巢癌分期进展。
Aging (Albany NY). 2019 Dec 3;11(23):11416-11439. doi: 10.18632/aging.102538.
10
miR‑501‑3p promotes colorectal cancer progression via activation of Wnt/β‑catenin signaling.miR-501-3p 通过激活 Wnt/β-连环蛋白信号通路促进结直肠癌的进展。
Int J Oncol. 2019 Sep;55(3):671-683. doi: 10.3892/ijo.2019.4852. Epub 2019 Jul 30.